NASDAQ:RPID
Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc.'s revenue grew 19.7% in fiscal 2025 to $33.6M while operating margin rose to −141.1%, its highest in 6 years. Free cash flow was −$31.9M, −95.0% of revenue, and the diluted share count rose 2.5%.Summary generated from Rapid Micro Biosystems, Inc.'s SEC filings. Latest annual report filed Mar 12, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$33.6M
Revenue growth+19.7%
Revenue, 5-yr CAGR+15.9%
Gross marginn/a
Operating margin−141.1%
Net margin−140.3%
ROIC−82.7%
Return on equity−86.8%
Debt / equity0.57
Free cash flow−$31.9M
FCF margin−95.0%
Share count change+2.5%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 23 | 17 | 23 | 28 | 34 |
| Operating income | −47 | −63 | −57 | −50 | −47 |
| Net income | −74 | −61 | −52 | −47 | −47 |
| Free cash flow | −58 | −65 | −47 | −46 | −32 |
Recent filings
- 10-QQuarterly report for the period ended Jun 30, 2026
Aug 7, 2026 - 8-KResults of operations and financial condition
Aug 7, 2026 - 4Insider transaction report
Jul 24, 2026 - 4Insider transaction report
Jul 24, 2026 - 8-KResults of a shareholder vote
May 28, 2026 - 8-KEntry into a material agreement
May 19, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 15, 2026 - 8-KResults of operations and financial condition
May 13, 2026